Osborne Clarke, an international legal practice, recently accomplished the sale of Cherwell Laboratories Limited, a dominant force in the cleanroom microbiology solutions market, to the AnalytiChem group. This move represents a significant development in the life sciences sector, as Cherwell, a company founded in 1971 and based in Bicester, Oxfordshire, joins forces with Germany’s AnalytiChem, enhanced by the financial backing of US-based private equity investor Battery Ventures. Cherwell’s principal, Andy Whittard, is set to maintain his leadership role as Managing Director, continuing the journey his father started over four decades ago. The transaction process was helmed by Osborne Clarke’s Partner Justin Starling, along with a cohort of experts from different departments within the firm. The sale marks a strategic growth point for AnalytiChem, which houses a portfolio of life sciences entities supplying laboratories globally with critical supplies. Osborne Clarke’s corporate team leveraged its extensive experience in advising the life science and healthcare sectors to facilitate this transaction, further solidifying its reputation for guiding companies through complex deals and highlighting its ability to support organizations across all corporate fronts, from funding to mergers and joint ventures.
“Legal Services”, “Life Sciences”, “Private Equity”,”United Kingdom”, “Germany”, “United States”
https://www.osborneclarke.com/news/osborne-clarke-advises-sale-cherwell-laboratories-limited-analytichem-group